nad has been researched along with 23-hydroxybetulinic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Liu, J; Lu, L; Tan, Y; Xu, J; Xu, S; Ye, W; Zhu, H; Zhu, W; Zhu, Z | 1 |
1 other study(ies) available for nad and 23-hydroxybetulinic acid
| Article | Year |
|---|---|
Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; NAD; NAD(P)H Dehydrogenase (Quinone); Prodrugs; Quinones; Triterpenes | 2022 |